Biosimilar User Fee Act

E1689555 UNEXPLORED

The Biosimilar User Fee Act is a U.S. law that authorizes the FDA to collect fees from biosimilar drug manufacturers to support the review and regulation of biosimilar products.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Biosimilar User Fee Act canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Food and Drug Administration Safety and Innovation Act of 2012 → hasComponent → Biosimilar User Fee Act ⓘ